Search

everythinglearnresearchcommunity

for

Search:↓

Sustained-release sodium valproate is effective in treating epilepsy, with some side effects influenced by genetics.

Tacrolimus is an effective treatment for several skin conditions with fewer side effects than cyclosporine.

Melatonin may inhibit melanoma growth and has potential as a cancer therapy aid, but its effects on human skin pigmentation need more research.

Using a special laser and skin medication together successfully cleared a skin condition in a pregnant woman.

Rebamipide may help regrow hair by activating hair follicle stem cells.

Identified genes linked to male-pattern baldness may help develop new treatments.

Finasteride, a hair loss drug, has unaddressed sexual side effects due to the manufacturer's inadequate safety measures and lack of additional studies.

The drug Albendazole, used for treating parasites, can cause sudden hair loss.

Finasteride can cause lasting sexual and mood issues even after stopping the drug.

The document concludes that an experimental drug may help wound healing in Epidermolysis Bullosa, links Hydroa vacciniforme to EBV, discusses diagnosing hair loss disorders, finds many children with eczema have allergies, reviews the safety of a skin medication in children, notes side effects of a Duchenne's treatment, and identifies a marker for pediatric mastocytosis.

Finasteride, a hair loss drug, can cause sexual side effects like erectile dysfunction in 2.1%-3.8% of users, but these usually go away with time or if the drug is stopped. Despite this, its impact on sexual function is minimal for most men.

Using electronic health records can help identify drug side effects but has some limitations.

A drug called cimetidine can help treat hair loss in women by blocking androgen receptors. However, it's not the first choice and needs more research.

Finasteride's molecular and crystal structures help develop new drug formulations.

Spironolactone may cause sexual pain and arousal issues in women, which can improve after stopping the drug and using hormone cream.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Combination drug therapies are more effective for high-risk BPS patients but have more side effects and costs.

A new device, IVL-PPF Microsphere®, was created to deliver a hair loss drug for up to 3 months with one injection, potentially replacing daily pills.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

This document studied minoxidil in healthy volunteers. Minoxidil is quickly absorbed and eliminated from the body.

Hair antiretroviral concentration is affected by hair type, segment position, housing, drug use, sexual behavior, kidney function, and genetics.

Off-label drug use can be risky and requires careful consideration to ensure patient safety.

Minoxidil is the only drug proven to improve female hair loss, and dextroamphetamine sulfate may be a new treatment for certain types of hair loss.

Finasteride may decrease semen quality but not harm sperm production, and stopping the drug can improve semen quality; hyperprolactinemia can cause infertility but is treatable with medication.

Non-drug treatments like saw palmetto, horsetail, pumpkin seed oil, curcumin, and addressing nutritional deficiencies may help female hair loss.

Non-drug therapies show promise for hair regrowth but need more research.

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

The new drug delivery systems made with surfactants and block polymers are stable and not toxic.

Levodopa for Parkinson's disease might be linked to skin issues like melanoma, but it's unclear if the drug or the disease causes them.